Polyrizon (PLRZ) announced Monday the publication of its national phase patent application with the US Patent and Trademark Office.
The application covers its core nasal technologies: capture and contain, a blocker system, and trap and target, designed for advanced drug delivery.
US patent applications are generally published after 18 months from the date of filing.
Shares of the company jumped more than 60% in recent premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.